Major clinical stories and read-outs from key conferences for the cell and gene therapy space

Cell & Gene Therapy Insights 2020; 6(9), 1549–1554

10.18609/cgti.2020.170

Published: 25 November 2020
Commentary
Sven Kili

2020 has certainly been a testing year for all of us! One particular headache for the life sciences world has been the loss of live conferences. For so many of us, they represent a great opportunity to take the pulse of the field we work in: to make new contacts, catch up with friends, identify and track trends that might impact our work, and get updated on the latest scientific/technical breakthroughs.

Whilst many of the key conferences for the cell and gene therapy space have persevered online, it can be challenging to immerse oneself in these virtual events as much as one might wish, due to time zone differences and the pressures of the day-to-day workload being that much closer to hand. This final Clinical Insights edition of 2020 highlights some of the notable clinical development-related trends, stories, and data readouts from two important recent conferences for cell and gene therapy, which you might have missed.